Atlas Trials

The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylitis Patients

Clinical trial NCT05527444 · UNKNOWN

Trial details

NCT number
NCT05527444
Sponsor
Qilu Hospital of Shandong University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Ankylosing Spondylitis
Start date
2022-03-15
Primary completion
2024-12-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.